Authors:
Ibrahim, NK
Valero, V
Rahman, Z
Theriault, RL
Walters, RS
Buzdar, AU
Booser, DJ
Holmes, FA
Murray, DJ
Willey, J
Bast, R
Hortobagyi, GN
Citation: Nk. Ibrahim et al., Phase I-II vinorelbine (Navelbine((R))) by continuous infusion in patientswith metastatic breast cancer: Cumulative toxicities limit dose escalation, CANCER INV, 19(5), 2001, pp. 459-466
Citation: Rj. Snowden et al., Visuospatial attention: the role of target contrast and task difficulty when assessing the effects of cues, PERCEPTION, 30(8), 2001, pp. 983-991
Authors:
Jaborek-Hugo, S
von Holst, C
Allen, R
Stewart, T
Willey, J
Anklam, E
Citation: S. Jaborek-hugo et al., Use of an immunoassay as a means to detect polychlorinated biphenyls in animal fat, FOOD ADDIT, 18(2), 2001, pp. 121-127
Authors:
Ibrahim, NK
Buzdar, AU
Valero, V
Dhingra, K
Willey, J
Hortobagyi, GN
Citation: Nk. Ibrahim et al., Phase I study of vinorelbine and paclitaxel by 3-hour simultaneous infusion with and without granulocyte colony-stimulating factor support in metastatic breast carcinoma, CANCER, 91(4), 2001, pp. 664-671
Authors:
Ibrahim, NK
Valero, V
Theriault, RL
Willey, J
Walters, RS
Buzdar, AU
Booser, DJ
Hortobagyi, GN
Citation: Nk. Ibrahim et al., Phase I study of vinorelbine by 96-hour infusion in advanced metastatic breast cancer, AM J CL ONC, 23(2), 2000, pp. 117-121
Authors:
Holmes, FA
Valero, V
Walters, RS
Theriault, RL
Booser, DJ
Gibbs, H
Fraschini, G
Buzdar, AU
Willey, J
Frye, D
Asmar, L
Hortobagyi, GN
Citation: Fa. Holmes et al., Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: Phase I results, ANN ONCOL, 10(4), 1999, pp. 403-411
Authors:
Valero, V
Buzdar, AU
Theriault, RL
Azarnia, N
Fonseca, GA
Willey, J
Ewer, M
Walters, RS
Mackay, B
Podoloff, D
Booser, D
Lee, LW
Hortobagyi, GN
Citation: V. Valero et al., Phase II trial of liposome-encapsulated doxorubicin, cyclophosphamide, andfluorouracil as first-line therapy in patients with metastatic breast cancer, J CL ONCOL, 17(5), 1999, pp. 1425-1434
Authors:
Ibrahim, NK
Rahman, Z
Valero, V
Willey, J
Theriault, RL
Buzdar, AU
Murray, JL
Bast, R
Hortobagyi, GN
Citation: Nk. Ibrahim et al., Phase II study of vinorelbine administered by 96-hour infusion in patientswith advanced breast carcinoma, CANCER, 86(7), 1999, pp. 1251-1257